Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
mRNA | ITGAL | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
mRNA | PTPN7 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-08 |
mRNA | LST1 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
mRNA | PPP1R27 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |